do you need to stop tirzepatide before surgery how long should i When Mounjaro Surgery: UK Perioperative Guidance Restarting Tirzepatide After Surgery: Safety – do you need to stop

FFAR1 is expressed in the pancreatic -cell, where evidence suggests it can influence glucose-stimulated insulin release (197)

Mounjaro, like other chronic disease medications, is generally intended for long-term use

These may include: Nausea and stomach upset Particularly when taken on an empty stomach Diarrhoea May be more common with higher doses Loss of appetite Occasionally reported in sensitive individuals Abdominal discomfort Mild cramping or bloating Beyond digestive symptoms, some individuals report non-gastrointestinal effects such as headaches, dizziness, fatigue, or skin rashes

If you have received a letter stopping your vital lifelong treatment then why not find your CCG and talk to the Medicines Optimisation department about what is happening